Accendra Health, Inc.ACHNYSE
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank77
3Y CAGR+73.1%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+73.1%/yr
vs +5.8%/yr prior
Acceleration
+67.3pp
Accelerating
Percentile
P77
Within normal range
vs 3Y Ago
5.2x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 139.52% |
| Q3 2025 | -558.71% |
| Q2 2025 | 207.25% |
| Q1 2025 | -149.39% |
| Q4 2024 | 160.01% |
| Q3 2024 | -76.49% |
| Q2 2024 | 319.31% |
| Q1 2024 | -147.39% |
| Q4 2023 | -29.01% |
| Q3 2023 | -49.72% |
| Q2 2023 | 97.67% |
| Q1 2023 | 82.15% |
| Q4 2022 | 26.91% |
| Q3 2022 | -23.72% |
| Q2 2022 | 12.71% |
| Q1 2022 | 58.32% |
| Q4 2021 | -18.05% |
| Q3 2021 | 571.92% |
| Q2 2021 | -151.20% |
| Q1 2021 | -58.09% |
| Q4 2020 | -48.48% |
| Q3 2020 | 106.55% |
| Q2 2020 | -39.00% |
| Q1 2020 | 246.38% |
| Q4 2019 | -75.49% |
| Q3 2019 | 22.43% |
| Q2 2019 | 247.64% |
| Q1 2019 | -780.12% |
| Q4 2018 | -109.07% |
| Q3 2018 | 172.54% |
| Q2 2018 | 53.12% |
| Q1 2018 | -64.26% |
| Q4 2017 | -41.99% |
| Q3 2017 | 257.01% |
| Q2 2017 | -112.96% |
| Q1 2017 | -161.16% |
| Q4 2016 | -57.41% |
| Q3 2016 | 4583.52% |
| Q2 2016 | -105.03% |
| Q1 2016 | -29.36% |